Fluctuating Immune Reconstitution and Delayed HIV-1 DNA Decline in People Living with HIV with Low CD4 on Bictegravir-Based Therapy
{{output}}
This prospective cohort study compared the efficacy of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and tenofovir/lamivudine/efavirenz (TLE) regimens in 88 treatment-naïve persons living with HIV. The BIC regimen achieved faster HIV-1 RNA sup... ...
